Quantum computers could eventually solve scientific problems beyond the reach of conventional supercomputers, but today’s machines are too error-prone for practical work. The US Department of Energy ...

Earlier this month, artificial intelligence researcher Jacob Coxon resigned from Anthropic after just four months. In an announcement on X, he stated: "The people building AI earnestly believe that it ...

Tailoring cancer treatments is a science and an art. The same type of tumor can behave very differently from one person to the next, and a drug that works for one patient may fail in another. The ...

Atlases have long guided us through uncharted territory. Now, an AI-generated atlas by Google DeepMind seeks to do the same for the vast landscape of our DNA. Ever since the Human Genome Project, ...

A potentially safer, simpler way to create CAR T cells in the body could bring this powerful therapy to the masses. When the body goes to war on itself, it wreaks havoc. The immune system is one of ...

The system, designed by Stanford researchers, identified which drugs are more likely to succeed in trials and even proposed a cancer treatment a major drugmaker later landed on too. Developing a new ...

The boy, whose liver cancer had spread to his lungs, suffered no dangerous side effects and remained cancer-free a year later. At just three years of age, the boy had already been through the medical ...

We're fixated on the intelligence of single agents. The more profound challenge is what happens when millions of them interact at scale. There is a temptation to divide the future of AI into two ...

Startup Isar Aerospace delivered a payload of satellites to orbit on its second try. Rivals in Germany and Spain are hot on its heels. Europe has long had to choose between state-backed rocket maker ...

Incumbents are racing to add AI to their organizations. The bigger challenge is competing with businesses designed around AI from day one. For many established companies, the AI conversation starts ...

Elderly mice on the popular weight-loss drug semaglutide aged slower and lived longer, mimicking the longevity effects of caloric restriction. It’s a hot GLP-1 drug summer. Semaglutide—better known as ...

OpenAI’s Navier-Stokes solution looks like a win for mathematics. But some mathematicians aren't so sure. And this is what seems to have happened here. Building on the work of several human ...